Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Sullivan Christopher Ryan
Over the trailing 90 days, Sullivan Christopher Ryan (Other at Avalo Therapeutics, Inc.) traded $2.0M of stock (net selling $838K) in AVTX, per 12 SEC Form 4 transactions.
- Role
- Other
- Companies
- AVTX
- Window
- Trailing 90 days · 12 transactions · CIK 1810417
- Net activity
- −$838K ($562K bought · $1.4M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 12 | $562K | $1.4M | −$838K |
Transactions (12)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-10 | AVTX | Sell | 138 | $2K | Payment of exercise price or tax liability by delivering securities |
| 2026-05-21 | AVTX | Buy | 39.9K | $0 | Grant, award or other acquisition |
| 2026-05-07 | AVTX | Sell | 18.6K | $0 | Exercise or conversion of derivative security |
| 2026-05-07 | AVTX | Sell | 18.6K | $449K | Open market or private sale |
| 2026-05-07 | AVTX | Buy | 18.6K | $184K | Exercise or conversion of derivative security |
| 2026-05-06 | AVTX | Sell | 47.0K | $0 | Exercise or conversion of derivative security |
| 2026-05-06 | AVTX | Buy | 47.0K | $378K | Exercise or conversion of derivative security |
| 2026-05-06 | AVTX | Sell | 2.7K | $56K | Open market or private sale |
| 2026-05-06 | AVTX | Sell | 8.9K | $201K | Open market or private sale |
| 2026-05-06 | AVTX | Sell | 12.3K | $238K | Open market or private sale |
| 2026-05-06 | AVTX | Sell | 9.2K | $197K | Open market or private sale |
| 2026-05-06 | AVTX | Sell | 13.8K | $257K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Sullivan's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.